BNTX
BioNTech SE is a biotechnology company developing immunotherapies and mRNA vaccines to improve health worldwide. It focuses on oncology with a diversified pipeline including mRNA cancer immunotherapies, immunomodulators, and targeted therapies, as well as programs in infectious diseases. The company emphasizes scientific rigor, innovation, and collaboration to advance therapies from research to clinical use. Headquartered in Mainz, Germany, BioNTech operates globally to address cancer, infectious diseases, and other serious illnesses.
No recent deals for this company.